Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP503519.RACdADrUo8EoStnbm4kPsfcNhw8gqSbSS24VChph6jPa0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP503519.RACdADrUo8EoStnbm4kPsfcNhw8gqSbSS24VChph6jPa0130_assertion type Assertion NP503519.RACdADrUo8EoStnbm4kPsfcNhw8gqSbSS24VChph6jPa0130_head.
- NP503519.RACdADrUo8EoStnbm4kPsfcNhw8gqSbSS24VChph6jPa0130_assertion description "[Th2 [interleukin (IL)-6, leukemia inhibitory factor and oncostatin M] and Th3 (transforming growth factor-beta1, 2, 3) cytokine and their receptor transcripts were strongly expressed in almost all glioblastomas and glioma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503519.RACdADrUo8EoStnbm4kPsfcNhw8gqSbSS24VChph6jPa0130_provenance.
- NP503519.RACdADrUo8EoStnbm4kPsfcNhw8gqSbSS24VChph6jPa0130_assertion evidence source_evidence_literature NP503519.RACdADrUo8EoStnbm4kPsfcNhw8gqSbSS24VChph6jPa0130_provenance.
- NP503519.RACdADrUo8EoStnbm4kPsfcNhw8gqSbSS24VChph6jPa0130_assertion SIO_000772 11810184 NP503519.RACdADrUo8EoStnbm4kPsfcNhw8gqSbSS24VChph6jPa0130_provenance.
- NP503519.RACdADrUo8EoStnbm4kPsfcNhw8gqSbSS24VChph6jPa0130_assertion wasDerivedFrom befree-20140225 NP503519.RACdADrUo8EoStnbm4kPsfcNhw8gqSbSS24VChph6jPa0130_provenance.
- NP503519.RACdADrUo8EoStnbm4kPsfcNhw8gqSbSS24VChph6jPa0130_assertion wasGeneratedBy ECO_0000203 NP503519.RACdADrUo8EoStnbm4kPsfcNhw8gqSbSS24VChph6jPa0130_provenance.